Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease
Launched by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST · Apr 2, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help patients with chronic obstructive pulmonary disease (COPD) who have recently been discharged from the hospital after a worsening of their condition, known as an exacerbation. The aim is to see if providing patients with a "rescue pack" of medications, along with a self-management plan and regular check-ins via phone or text, can reduce the chances of them needing to return to the hospital within 90 days. Researchers hope that this approach will improve patient outcomes and potentially save money for the healthcare system.
To be eligible for the study, participants must be at least 40 years old and have been hospitalized for a COPD exacerbation. They should also be able to give informed consent and manage their own care with some support. Those who may not qualify include individuals needing special breathing support during their hospital stay, patients with serious health issues affecting their survival, or those living in care facilities. If you join the trial, you can expect to receive the rescue pack and self-management tools, along with regular follow-ups to monitor your symptoms and health. Your participation could help improve care for others with COPD in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 40 years
- • Individuals admitted to hospital with COPD exacerbation who have recently been discharged (discharged from ongoing support from secondary care team which includes hospital and virtual wards). Admission is defined as an episode in which a patient with an exacerbation of COPD is admitted to a ward and has stayed in hospital for 4 hours or more, including Emergency Medicine Centres, Medical Admission Units, Clinical Decision Units, short stay wards or similar but excludes patients treated transiently before being discharged from Emergency Department.
- • Ability to provide written informed consent
- Exclusion Criteria:
- • Individuals who require invasive ventilation during the hospital admission
- • Patients who have an expected survival of less than 90 days
- • Patients with signs of new consolidation on chest X-ray (if available).
- • Individuals who have been discharged to a residential or nursing home to residential or nursing home.
- • Individuals who are unable to manage a supported self-management plan.
- • Individuals with no access to telephone.
- • Individuals who are already taking part in an interventional trial.
- • Previous participation in the RAPID trial.
About Guy's And St Thomas' Nhs Foundation Trust
Guy's and St Thomas' NHS Foundation Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and clinical excellence. As a prominent academic health science center, the Trust integrates cutting-edge research with clinical practice, facilitating the translation of scientific discoveries into improved treatment options. With a diverse portfolio of clinical trials across various medical specialties, Guy's and St Thomas' NHS Foundation Trust plays a pivotal role in advancing healthcare knowledge and enhancing patient outcomes, while maintaining the highest ethical standards in research and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Leicester, , United Kingdom
London, , United Kingdom
London, , United Kingdom
Blackpool, , United Kingdom
Maidstone, , United Kingdom
London, , United Kingdom
Milton Keynes, , United Kingdom
Bradford, , United Kingdom
Lancaster, , United Kingdom
Newcastle Upon Tyne, , United Kingdom
Oxford, , United Kingdom
Salisbury, , United Kingdom
Slough, , United Kingdom
Stockport, , United Kingdom
Sutton In Ashfield, , United Kingdom
Barnsley, , United Kingdom
Llandough, , United Kingdom
Durham, , United Kingdom
North Shields, , United Kingdom
Stockton On Tees, , United Kingdom
London, , United Kingdom
Whiston, , United Kingdom
Brighton, , United Kingdom
Birmingham, , United Kingdom
Bristol, , United Kingdom
Ipswich, , United Kingdom
Middlesbrough, , United Kingdom
Nottingham, , United Kingdom
Shirley, , United Kingdom
South Shields, , United Kingdom
Taunton, , United Kingdom
Yeovil, , United Kingdom
Gateshead, , United Kingdom
Rotherham, , United Kingdom
Southport, , United Kingdom
Patients applied
Trial Officials
Mona Bafadhel, Professor
Principal Investigator
King's College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported